Skip to Main Content

Paper Details

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome.
Ann Intensive Care
47
2014
Author NameAffiliation
Kathleen D LiuUniversity of California san francisco
Jennifer G WilsonUniversity of California san francisco
Carolyn S CalfeeUniversity of California san francisco
Boyd Taylor ThompsonMassachusetts General Hospital
Michael A MatthayDepartments of Medicine and Anesthesia and the Cardiovascular Research Institute, University of California san francisco
  • 1 - 5

Datasets

Release 1.2